Related Experiment Video
Updated: Jun 15, 2026
Simple Establishment of a Vascularized Osteogenic Bone Marrow Niche Using Pre-Cast Poly(ethylene Glycol) (PEG) Hydrogels in an Imaging Microplate
Published on: May 19, 2023
OP-1 (BMP-7) stimulates osteoprogenitor cell differentiation in the presence of polymethylmethacrylate particles
Shawn Kann1, Richard Chiu, Ting Ma
1Department of Orthopaedic Surgery, Stanford University Medical Center, Stanford, California, USA.
Abstract:
Polymethylmethacrylate (PMMA) particles have been shown to inhibit the differentiation, proliferation, and mineralization of osteoprogenitor cells in vitro. In this study, we investigated the effects of OP-1 (BMP-7) on the osteogenesis of MC3T3-E1 osteoprogenitor cells exposed to PMMA particles in vitro. MC3T3-E1 cells challenged with PMMA particles on the 1st day of differentiation in osteogenic culture showed a significant dose-dependent decrease in mineralization and alkaline phosphatase expression over a 20-day culture period. Exposure of these cells to OP-1 (200 ng/mL) during days 1-4, 1-20, and 4-20 in the presence of PMMA particles resulted in significant increases in mineralization and alkaline phosphatase expression at all particle doses. Addition of OP-1 to MC3T3-E1 cultures challenged with PMMA particles on the 4th day of differentiation in osteogenic media also resulted in significant increases in mineralization and alkaline phosphatase expression. This study has shown that OP-1 stimulates osteogenesis in MC3T3-E1 osteoprogenitor cells that have been inhibited by PMMA particles. Local administration of OP-1 to the site of osteolysis may be a potential adjunctive therapy to reverse the bone destruction due to wear particles.
Insights
Bone morphogenetic protein-7 (OP-1) can reverse the inhibitory effects of polymethylmethacrylate (PMMA) particles on bone cell growth and function. This suggests OP-1 may be a potential therapy for bone destruction caused by wear particles.
Area of Science:
- Biomaterials Science
- Cell Biology
- Orthopedic Research
Background:
- Polymethylmethacrylate (PMMA) particles are known to impede osteoprogenitor cell differentiation, proliferation, and mineralization.
- Understanding cellular responses to biomaterial wear particles is crucial for improving orthopedic implant longevity.
Purpose of the Study:
- To investigate the potential of OP-1 (BMP-7) to counteract the negative effects of PMMA particles on osteogenesis in MC3T3-E1 osteoprogenitor cells.
- To evaluate OP-1's efficacy in stimulating bone formation in an in vitro model of PMMA-induced osteolysis.
Main Methods:
- MC3T3-E1 osteoprogenitor cells were cultured in osteogenic media and exposed to varying doses of PMMA particles.
- OP-1 (BMP-7) was administered at different time points and durations in combination with PMMA particles.
- Mineralization and alkaline phosphatase (ALP) expression were measured as indicators of osteogenesis.
Main Results:
- PMMA particles significantly inhibited mineralization and ALP expression in a dose-dependent manner.
- OP-1 treatment significantly increased mineralization and ALP expression, even in the presence of PMMA particles, across all tested administration timings.
- OP-1 demonstrated a restorative effect on osteogenesis inhibited by PMMA particles.
Conclusions:
- OP-1 effectively stimulates osteogenesis in osteoprogenitor cells affected by PMMA particle inhibition.
- Local administration of OP-1 could be a promising adjunctive therapy to mitigate bone loss associated with wear particles from orthopedic implants.
